Literature DB >> 26284909

Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes.

A-C Bursztejn1, T A Briggs2, Y del Toro Duany3, B H Anderson2, J O'Sullivan2, S G Williams2, C Bodemer4, S Fraitag5, F Gebhard6, B Leheup7, I Lemelle8, A Oojageer2, E Raffo7, E Schmitt9, G I Rice2, S Hur3, Y J Crow2,10.   

Abstract

Cutaneous lesions described as chilblain lupus occur in the context of familial chilblain lupus or Aicardi-Goutières syndrome. To date, seven genes related to Aicardi-Goutières syndrome have been described. The most recently described encodes the cytosolic double-stranded RNA receptor IFIH1 (also known as MDA5), a key component of the antiviral type I interferon-mediated innate immune response. Enhanced type I interferon signalling secondary to gain-of-function mutations in IFIH1 can result in a range of neuroinflammatory phenotypes including classical Aicardi-Goutières syndrome. It is of note that none of the patients with a neurological phenotype so far described with mutations in this gene was reported to demonstrate cutaneous involvement. We present a family segregating a heterozygous pathogenic mutation in IFIH1 showing dermatological involvement as a prominent feature, variably associated with neurological disturbance and premature tooth loss. All three affected individuals exhibited increased expression of interferon-stimulated genes in whole blood, and the mutant protein resulted in enhanced interferon signalling in vitro, both in the basal state and following ligand stimulation. Our results further extend the phenotypic spectrum associated with mutations in IFIH1, indicating that the disease can be confined predominantly to the skin, while also highlighting phenotypic overlap with both Aicardi-Goutières syndrome and Singleton-Merten syndrome.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284909      PMCID: PMC4745891          DOI: 10.1111/bjd.14073

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  21 in total

1.  Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3'-repair exonuclease 1.

Authors:  Kazumitsu Sugiura; Takuya Takeichi; Michihiro Kono; Yasuki Ito; Yasushi Ogawa; Yoshinao Muro; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2012-06-21       Impact factor: 8.551

2.  Red and purple papules on the dorsum of fingers and toes in a woman.

Authors:  Maria Paloma Arribas; Maria Albares; Pilar Soro; Isabel Belinchon
Journal:  Int J Dermatol       Date:  2013-11       Impact factor: 2.736

Review 3.  Type I interferonopathies: mendelian type I interferon up-regulation.

Authors:  Yanick J Crow
Journal:  Curr Opin Immunol       Date:  2014-10-30       Impact factor: 7.486

4.  Activated STING in a vascular and pulmonary syndrome.

Authors:  Y Liu; A A Jesus; B Marrero; Z Deng; M Boehm; A S Paller; D Yang; S E Ramsey; G A Montealegre Sanchez; K Tenbrock; H Wittkowski; O Y Jones; H S Kuehn; C-C R Lee; M A DiMattia; E W Cowen; B Gonzalez; I Palmer; J J DiGiovanna; A Biancotto; H Kim; W L Tsai; A M Trier; Y Huang; D L Stone; S Hill; H J Kim; C St Hilaire; S Gurprasad; N Plass; D Chapelle; I Horkayne-Szakaly; D Foell; A Barysenka; F Candotti; S M Holland; J D Hughes; H Mehmet; A C Issekutz; M Raffeld; J McElwee; J R Fontana; C P Minniti; S Moir; D L Kastner; M Gadina; A C Steven; P T Wingfield; S R Brooks; S D Rosenzweig; T A Fleisher; R Goldbach-Mansky
Journal:  N Engl J Med       Date:  2014-07-16       Impact factor: 91.245

5.  Early-onset stroke and vasculopathy associated with mutations in ADA2.

Authors:  Qing Zhou; Dan Yang; Amanda K Ombrello; Andrey V Zavialov; Camilo Toro; Anton V Zavialov; Deborah L Stone; Jae Jin Chae; Sergio D Rosenzweig; Kevin Bishop; Karyl S Barron; Hye Sun Kuehn; Patrycja Hoffmann; Alejandra Negro; Wanxia L Tsai; Edward W Cowen; Wuhong Pei; Joshua D Milner; Christopher Silvin; Theo Heller; David T Chin; Nicholas J Patronas; John S Barber; Chyi-Chia R Lee; Geryl M Wood; Alexander Ling; Susan J Kelly; David E Kleiner; James C Mullikin; Nancy J Ganson; Heidi H Kong; Sophie Hambleton; Fabio Candotti; Martha M Quezado; Katherine R Calvo; Hawwa Alao; Beverly K Barham; Anne Jones; James F Meschia; Bradford B Worrall; Scott E Kasner; Stephen S Rich; Raphaela Goldbach-Mansky; Mario Abinun; Elizabeth Chalom; Alisa C Gotte; Marilynn Punaro; Virginia Pascual; James W Verbsky; Troy R Torgerson; Nora G Singer; Timothy R Gershon; Seza Ozen; Omer Karadag; Thomas A Fleisher; Elaine F Remmers; Shawn M Burgess; Susan L Moir; Massimo Gadina; Raman Sood; Michael S Hershfield; Manfred Boehm; Daniel L Kastner; Ivona Aksentijevich
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

6.  A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome.

Authors:  Frank Rutsch; Mary MacDougall; Changming Lu; Insa Buers; Olga Mamaeva; Yvonne Nitschke; Gillian I Rice; Heidi Erlandsen; Hans Gerd Kehl; Holger Thiele; Peter Nürnberg; Wolfgang Höhne; Yanick J Crow; Annette Feigenbaum; Raoul C Hennekam
Journal:  Am J Hum Genet       Date:  2015-01-22       Impact factor: 11.025

7.  Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome.

Authors:  Mi-Ae Jang; Eun Kyoung Kim; Hesung Now; Nhung T H Nguyen; Woo-Jong Kim; Joo-Yeon Yoo; Jinhyuk Lee; Yun-Mi Jeong; Cheol-Hee Kim; Ok-Hwa Kim; Seongsoo Sohn; Seong-Hyeuk Nam; Yoojin Hong; Yong Seok Lee; Sung-A Chang; Shin Yi Jang; Jong-Won Kim; Myung-Shik Lee; So Young Lim; Ki-Sun Sung; Ki-Tae Park; Byoung Joon Kim; Joo-Heung Lee; Duk-Kyung Kim; Changwon Kee; Chang-Seok Ki
Journal:  Am J Hum Genet       Date:  2015-01-22       Impact factor: 11.025

8.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

9.  Autoimmune disorders associated with gain of function of the intracellular sensor MDA5.

Authors:  Masahide Funabiki; Hiroki Kato; Yoshiki Miyachi; Hideaki Toki; Hiromi Motegi; Maki Inoue; Osamu Minowa; Aiko Yoshida; Katashi Deguchi; Hiroshi Sato; Sadayoshi Ito; Toshihiko Shiroishi; Kunio Takeyasu; Tetsuo Noda; Takashi Fujita
Journal:  Immunity       Date:  2014-02-13       Impact factor: 31.745

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  29 in total

Review 1.  Intracellular Nucleic Acid Detection in Autoimmunity.

Authors:  John T Crowl; Elizabeth E Gray; Kathleen Pestal; Hannah E Volkman; Daniel B Stetson
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

2.  Aicardi goutières syndrome is associated with pulmonary hypertension.

Authors:  Laura A Adang; David B Frank; Ahmed Gilani; Asako Takanohashi; Nicole Ulrick; Abigail Collins; Zachary Cross; Csaba Galambos; Guy Helman; Usama Kanaan; Stephanie Keller; Dawn Simon; Omar Sherbini; Brian D Hanna; Adeline L Vanderver
Journal:  Mol Genet Metab       Date:  2018-09-07       Impact factor: 4.797

3.  RNASEH2B Related Adult-Onset Interferonopathy.

Authors:  Tracy A Briggs; Anindita Paul; Gillian Rice; Ariane L Herrick
Journal:  J Clin Immunol       Date:  2019-07-31       Impact factor: 8.317

Review 4.  Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 5.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 6.  An Update on Autoinflammatory Diseases: Interferonopathies.

Authors:  Sophia Davidson; Annemarie Steiner; Cassandra R Harapas; Seth L Masters
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 7.  Double-Stranded RNA Sensors and Modulators in Innate Immunity.

Authors:  Sun Hur
Journal:  Annu Rev Immunol       Date:  2019-01-23       Impact factor: 28.527

8.  Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.

Authors:  Mona Motwani; Sudesh Pawaria; Jennifer Bernier; Stephanie Moses; Kate Henry; Terry Fang; Linda Burkly; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

Review 9.  MDA5-Associated Neuroinflammation and the Singleton-Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum.

Authors:  Insa Buers; Gillian I Rice; Yanick J Crow; Frank Rutsch
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

Review 10.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.